Skip to content

Congressional letter to FDA regarding DSCSA implementation concerns

21 members of Congress sent a letter to the FDA regarding concerns about DSCSA implementation.

WASHINGTON — Yesterday, 21 members of Congress sent a letter to the FDA regarding concerns about DSCSA implementation. The letter urges the agency to take additional action to minimize the potential for disruptions in the drug supply chain and patient care as the November 27 implementation deadline looms. Numerous groups, including HDA, have voiced their concerns about the industry’s preparedness and called for a phased-in approach to implementation.

To read the full letter, click here.

Latest

Danimals updates look and recipe

Danimals updates look and recipe

The update comes at a moment when many parents are looking for simple, trustworthy ways to support their growing children amid busy summer schedules and competing nutrition messages on social media.